At the highest dose, clinical trial patients lost about 10 pounds over a 9-month period - so while its not approved for weight loss, it may still have some weight-related benefits
Patreon: patreon.com/YourDietSucks bonus episodes, monthly Q&As with Kylee, and the community thread
GLP-1s are among the most promising medical breakthroughs in decades, helping patients struggling with diabetes, obesity and other chronic illnesses, Winegarden said
Athletic programs, particularly at the high school and collegiate levels, are increasingly incorporating nutrition-focused protocols as part of concussion management
Farxiga/Forxiga is not currently approved for weight loss as a standalone indication in non-diabetics, but the evidence is accumulating: Currently, if weight loss is the primary goal in a non-diabetic patient, GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) produce substantially greater weight loss (1015% vs 24%)
Mismatch repair, methylation, recombination and replication functions